Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP747205.RAR2nivuBxWUXjigGvPJd4hZdk6cVUw4HIRdILjA1S0j0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP747205.RAR2nivuBxWUXjigGvPJd4hZdk6cVUw4HIRdILjA1S0j0130_assertion type Assertion NP747205.RAR2nivuBxWUXjigGvPJd4hZdk6cVUw4HIRdILjA1S0j0130_head.
- NP747205.RAR2nivuBxWUXjigGvPJd4hZdk6cVUw4HIRdILjA1S0j0130_assertion wasGeneratedBy ECO_0000203 NP747205.RAR2nivuBxWUXjigGvPJd4hZdk6cVUw4HIRdILjA1S0j0130_provenance.
- NP747205.RAR2nivuBxWUXjigGvPJd4hZdk6cVUw4HIRdILjA1S0j0130_assertion wasDerivedFrom befree-20140225 NP747205.RAR2nivuBxWUXjigGvPJd4hZdk6cVUw4HIRdILjA1S0j0130_provenance.
- NP747205.RAR2nivuBxWUXjigGvPJd4hZdk6cVUw4HIRdILjA1S0j0130_assertion SIO_000772 19920204 NP747205.RAR2nivuBxWUXjigGvPJd4hZdk6cVUw4HIRdILjA1S0j0130_provenance.
- NP747205.RAR2nivuBxWUXjigGvPJd4hZdk6cVUw4HIRdILjA1S0j0130_assertion evidence source_evidence_literature NP747205.RAR2nivuBxWUXjigGvPJd4hZdk6cVUw4HIRdILjA1S0j0130_provenance.
- NP747205.RAR2nivuBxWUXjigGvPJd4hZdk6cVUw4HIRdILjA1S0j0130_assertion description "[Because most ER-negative breast tumors express mutant p53, our results provide the foundation for future development of p38 inhibitors to target p38 for the treatment of p53 mutant and ER-negative breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP747205.RAR2nivuBxWUXjigGvPJd4hZdk6cVUw4HIRdILjA1S0j0130_provenance.